[PH/MY/SG] Regional Therapeutic Area Leader (Glaucoma) at Santen

Manila, Metro Manila, Philippines -

Full Time

Start Date

Immediate

Expiry Date

12 May, 26

Salary

0.0

Posted On

11 Feb, 26

Experience

10 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Medical Affairs, Ophthalmology, Strategic Planning, KOL Management, Data Interpretation, Publication Planning, Regulatory Compliance, Clinical Research, Scientific Training, Stakeholder Engagement, Brand Development, Portfolio Strategy, Communication Skills, Team Collaboration, Patient-Centric Approach, Ethical Standards

Industry

Pharmaceutical Manufacturing

Description

Company Description Santen is a specialized company with a proud 130-year heritage focused exclusively on eye health. As a Japan-originated, global company with our footprint in over 60 countries and regions, our mission is to provide essential and significant value to patients and society through our products and services created from our expertise in ophthalmology and from the patient’s perspective. Due to significant expansion, Santen Asia is seeking a Regional Therapeutic Area Leader (Glaucoma), based either in the Philippines, Malaysia or Singapore. As a key member of the Global Medical Affairs TA Strategy Team, the Regional TA Leader provides critical functional expertise in the Glaucoma therapeutic area to support both global and regional product portfolios. In this role, the individual leads the development and tactical execution of regional medical and scientific strategies, ensuring they remain closely aligned with Santen’s global objectives while adapting them to meet specific regional needs. By cultivating professional relationships with internal and external stakeholders, the Leader serves as a vital bridge for clinical insights, providing the cross-functional guidance necessary to optimize brand strategies and empower local medical affairs teams. Job Description What you will do Develop and lead regional medical plans for prioritized products (pre-launch and commercial) in Asia, ensuring alignment with global strategies. Represent regional interests in Global TA Medical Sub-Teams, translating global strategies into local actions and sharing regional insights/clinical practices. Partner with regional teams to shape portfolio strategy, brand development, and commercial/promotional activities. Provide high-level medical input and formal approval for regional promotional and medical communication materials to ensure regulatory compliance. Build and maintain strategic partnerships with regional Key Opinion Leaders (KOLs), professional organizations, and patient advocacy groups. Identify clinical data gaps and lead the development of protocol concepts and study designs for post-registration, company-sponsored studies. Serve as the regional point of contact for IIS, overseeing the internal review and governance process for proposed investigator research. Facilitate the creation and dissemination of scientific evidence, including publication alerts, to keep internal and external stakeholders informed. Develop and deliver scientific training materials to internal teams, ensuring field sales and cross-functional partners are upskilled. Support study planning and site selection, providing essential medical training to investigators and site personnel during study start-up. Qualifications What you will bring to the role Must hold a Medical Degree (MD), PharmD, or PhD in a related life sciences field. Minimum of 8 years of experience in Medical Affairs, with a strong preference for candidates with an Ophthalmology background. Proven track record in developing and executing regional Medical Affairs strategies, including data interpretation and publication planning. Extensive experience in managing KOL relationships and leading high-level advisory board meetings. Strong ability to analyze complex medical, scientific, and technical information to translate data into actionable insights. Deep understanding of industry laws, regulations, and company policies, maintained with a strictly ethical, patient-centric approach. Excellent interpersonal and English communication skills, with the ability to influence senior management and thrive in a matrix organization. Demonstrated ability to challenge common perceptions and implement medical tools that measurably improve patient care and outcomes. Proactive ability to anticipate and respond to evolving customer needs, with the flexibility to travel as required. Additional Information Grow your career at Santen A career at Santen is an opportunity to make a difference. We aspire to contribute to the realization of “Happiness with Vision” by providing eye health products and services to patients, consumers, and medical professionals around the world. Guided by our CORE PRINCIPLE, “Tenki ni sanyo suru”, Santen is engaged in the global research & development, manufacturing, and sales and marketing of pharmaceutical products in opthlamology. We have team members around the world using their diverse talents to unlock new modalities and drive innovations for patient outcomes, education and treatment. At Santen, we believe in empowering all our team members with flexible ways of working and a highly inclusive work environment. The Santen Group is an Equal Opportunity Employer. We are committed to building diverse teams and ensuring a safe and inclusive physical and virtual workplace for every one of our team members. All employment decisions are based on business needs, role requirements and individual qualifications regardless of race, color, ethnicity, national origin/ancestry, religion, sexual orientation, gender, gender identity/ expression, age, disability, medical condition, marital status, veteran status, or any other characteristic protected by law. If you require any kind of accommodation during our recruitment process, please let the recruiter from our team know.

Responsibilities

The Regional Therapeutic Area Leader (Glaucoma) will develop and lead regional medical plans for prioritized products, ensuring alignment with global strategies. They will also build strategic partnerships with KOLs and oversee the development of clinical studies.